Editas Medicine
Develops an in vivo CRISPR candidate for lowering LDL cholesterol.
$3.14
After-hours close−0.01 (−0.30%)
At close$3.15(−4.55%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.27 | −$0.15 | +44.5% |
| May 2026 | −$0.30 | −$0.26 | +13.3% |
| Mar 2026 | −$0.27 | −$0.06 | +77.8% |
| Nov 2025 | −$0.38 | −$0.28 | +26.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Feb 2016 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.21 | — | — | $4.5M | — | — |
| Aug 5, 2026 | −$0.27 | −$0.15 | +44.5% | $2.8M | $11.9M | +317.7% |
| May 5, 2026 | −$0.30 | −$0.26 | +13.3% | $6.4M | $2.8M | −55.6% |
| Mar 9, 2026 | −$0.27 | −$0.06 | +77.8% | $8.3M | $24.7M | +196.3% |
| Nov 10, 2025 | −$0.38 | −$0.28 | +26.3% | $8.5M | $7.5M | −10.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 5, 2025 | ||||||
| Nov 4, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 28, 2024 | ||||||
| Nov 3, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 5, 2023 | ||||||
| Feb 22, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 4, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 5, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 26, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 28, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 6, 2018 | ||||||
| May 3, 2018 | ||||||
| Mar 6, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 15, 2017 | ||||||
| Mar 7, 2017 | ||||||
| Nov 7, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 16, 2016 | ||||||
| Mar 30, 2016 | ||||||
| Feb 3, 2016 | ||||||
| Jun 30, 2015 | ||||||